Merrimack Pharmaceuticals, Inc

(NASDAQ:MACK)

Latest On Merrimack Pharmaceuticals, Inc (MACK):

Date/Time Type Description Signal Details
2023-05-05 02:53 ESTNewsMerrimack Pharmaceuticals GAAP EPS of $0.02N/A
2023-03-09 19:03 ESTNewsMerrimack Pharmaceuticals GAAP EPS of -$0.11N/A
2023-01-04 21:18 ESTNewsMerrimack Still Has Significant Arbitrage PotentialN/A
2022-11-09 08:17 ESTNewsMerrimack jumps 183% as partner Ipsen says pancreatic cancer trial met main goalN/A
2022-11-04 05:04 ESTNewsMerrimack Pharmaceuticals GAAP EPS of -$0.03N/A
2022-10-31 20:40 ESTNewsReturn Of The Mack: A Deeply Misunderstood Near-Term ReadoutN/A
2022-08-09 04:46 ESTNewsMerrimack Pharmaceuticals: Out For NowN/A
2022-08-05 04:53 ESTNewsMerrimack Pharmaceuticals GAAP EPS of -$0.04N/A
2022-05-06 04:50 ESTNewsMerrimack Pharmaceuticals GAAP EPS of -$0.01N/A
2021-03-12 08:04 ESTFinancialsCompany financials have been released.Neutral
2021-03-11 10:03 ESTNewsMerrimack Pharmaceuticals reports FY resultsN/A
2021-01-06 16:06 ESTFinancialsCompany financials have been released.Neutral
2020-12-03 02:38 ESTNewsMerrimack Pharma jumps 42% on bullish timeline for potential Onivyde milestone paymentN/A
2020-11-26 20:45 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 04:31 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:24 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 04:19 ESTFinancialsCompany financials have been released.Neutral
2020-11-05 08:40 ESTNewsMerrimack Pharmaceuticals reports Q3 resultsN/A
2020-09-26 13:19 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:26 ESTFinancialsCompany financials have been released.Neutral
2020-08-17 16:26 ESTInsider TradeEric Andersen has indirectly acquired of 609 shares.Buy
2020-08-17 16:26 ESTInsider TradeNoah G. Levy has indirectly acquired of 254 shares.Buy
2020-08-17 16:26 ESTInsider TradeNoah G. Levy has indirectly acquired of 354 shares.Buy
2020-08-14 09:23 ESTFinancialsCompany financials have been released.Neutral
2020-08-13 16:56 ESTInsider TradeNoah G. Levy has indirectly acquired of 834 shares.Buy
2020-08-13 16:56 ESTInsider TradeNoah G. Levy has indirectly acquired of 5,856 shares.Buy
2020-08-13 16:56 ESTInsider TradeNoah G. Levy has indirectly acquired of 1,166 shares.Buy
2020-08-13 16:56 ESTInsider TradeNoah G. Levy has indirectly acquired of 8,186 shares.Buy
2020-08-13 16:56 ESTInsider TradeEric Andersen has indirectly acquired of 2,000 shares.Buy
2020-08-13 16:56 ESTInsider TradeEric Andersen has indirectly acquired of 14,030 shares.Buy
2020-08-09 05:08 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 22:11 ESTNewsMerrimack Pharmaceuticals reports Q2 resultsN/A
2020-07-31 01:35 ESTFinancialsCompany financials have been released.Neutral
2020-07-24 19:22 ESTInsider TradeNoah G. Levy has indirectly acquired of 40,488 shares.Buy
2020-07-24 19:22 ESTInsider TradeNoah G. Levy has indirectly acquired of 33,435 shares.Buy
2020-07-24 19:22 ESTInsider TradeNoah G. Levy has indirectly acquired of 56,606 shares.Buy
2020-07-24 19:22 ESTInsider TradeNoah G. Levy has indirectly acquired of 46,745 shares.Buy
2020-07-24 19:22 ESTInsider TradeEric Andersen has indirectly acquired of 33,192 shares.Buy
2020-07-24 19:22 ESTInsider TradeEric Andersen has indirectly acquired of 17,404 shares.Buy
2020-07-24 19:22 ESTInsider TradeEric Andersen has indirectly acquired of 63,903 shares.Buy
2020-07-24 19:22 ESTInsider TradeEric Andersen has indirectly acquired of 62,775 shares.Buy
2020-07-24 19:22 ESTInsider TradeGARY L CROCKER has directly disposed of 5,986 shares and currently holds 0 shares.Sell
2020-07-24 19:22 ESTInsider TradeGARY L CROCKER has directly disposed of 17,000 shares and currently holds 0 shares.Sell
2020-07-23 17:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 09:17 ESTFinancialsCompany financials have been released.Neutral
2020-06-26 09:16 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 05:21 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 05:26 ESTFinancialsCompany financials have been released.Neutral
2020-05-10 05:11 ESTFinancialsCompany financials have been released.Neutral
2020-05-07 19:49 ESTNewsMerrimack Pharmaceuticals reports Q1 resultsN/A

About Merrimack Pharmaceuticals, Inc (MACK):

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was founded in 1993 and is headquartered in Cambridge, Massachusetts.

MACK Quotes by TradingView

See Advanced Chart

General

  • Name Merrimack Pharmaceuticals, Inc
  • Symbol MACK
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Last Split Factor1271:1000
  • Last Split Date2019-09-06
  • Fiscal Year EndDecember
  • IPO Date2012-03-29
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.merrimack.com
View More

Valuation

  • Trailing PE 65.1
  • Price/Book (Most Recent Quarter) 5.48
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Return on Assets -17%
  • Return on Equity -18%
  • Earnings Per Share $0.10
  • Revenue Per Share $0
  • Gross Profit -9100000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 93.24 million
  • EBITDA 134000
  • PEG Ratio 0.07
  • Analyst Target Price $4
  • Book Value Per Share $1.20
View More

Share Statistics

  • Shares Outstanding 13.41 million
  • Shares Float 8.11 million
  • % Held by Insiders 324%
  • % Held by Institutions 60.31%
  • Shares Short 576520
  • Shares Short Prior Month 589421
  • Short Ratio 4.24
  • Short % of Float 5%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 2.48
  • 52 Week High $9.35
  • 52 Week Low $1.49
  • 50 Day Moving Average 7.2
  • 200 Day Moving Average 5.64
View More

Dividends

  • Forward Annual Dividend Yield 57.71%
  • Dividend Date 2019-12-23
  • ExDividend Date 2019-12-13
  • Dividend Per Share $1.5
  • Dividend Yield 0%
View More

Merrimack Pharmaceuticals, Inc (MACK) Dividend Calendar:

MACK's last dividend payment was made to shareholders on December 23, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Merrimack Pharmaceuticals, Inc (MACK) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$N/A-$0.08
2020-09-302020-12-31$N/A-$0.09
2020-06-302020-09-30$N/A-$0.08
2020-03-312020-06-30$N/A-$0.09
2019-12-312020-03-31$N/A$0.02
2019-09-302019-11-11$N/A-$0.05
2019-06-302019-09-30$N/A-$0.05
2019-03-312019-06-30$N/A-$0.71
2018-12-312019-03-31$N/A-$0.78-$0.64-22.47%
2018-09-302018-12-31$N/A-$0.96-$0.60-61.98%
2018-06-302018-08-07$N/A-$1.33-$1.28-3.52%
2018-03-312018-05-08$N/A-$1.33-$1.28-3.91%
2017-12-312018-03-12$N/A-$1.08-$1.2714.97%
2017-09-302017-11-08$N/A$0.24-$1.90112.66%
2017-06-302017-08-09$N/A$38.60-$1.382890.83%
2017-03-312017-05-10$N/A-$2.30-$1.80-28.01%
2016-12-312017-03-01$61.24 million-$2.50-$2.09-19.9%
2016-09-302016-11-09$28.07 million-$2.30-$3.0123.47%
2016-06-302016-08-04$33.68 million-$4.00-$3.30-21.21%
2016-03-312016-05-02$21.28 million-$3.30-$3.7812.58%
2015-12-312016-02-25$21.42 million-$4.10-$3.98-3.14%
2015-09-302015-11-09$16.44 million-$3.80-$4.035.71%
2015-06-302015-08-10$36.56 million-$0.21-$0.3132.26%
2015-03-312015-05-07$14.84 million-$0.32-$0.29-10.34%
2014-12-312015-02-26$33.91 million-$0.09-$0.1952.63%
2014-09-302014-11-10$28 million-$0.27-$0.12-125%
2014-06-302014-08-11$27.82 million-$1.70-$3.0043.33%
2014-03-312014-05-01$13.03 million-$2.70-$2.958.47%
2013-12-312014-02-27$7.82 million-$3.30-$2.90-13.79%
2013-09-302013-11-07$6.86 million-$3.90-$3.07-27.04%
2013-06-302013-08-08$18.45 million-$3.10-$2.77-11.91%
2013-03-312013-05-13$14.66 million-$2.90-$2.77-4.69%
2012-12-312013-03-14$14.19 million-$2.60-$2.620.76%
2012-09-302012-11-14$11.32 million-$2.50-$2.583.1%
2012-06-302012-08-10$12.06 million-$2.20-$2.7018.52%
2012-03-312012-05-15$11.34 million-$21.38

Merrimack Pharmaceuticals, Inc (MACK) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A N/A N/A
Income Before Tax -1.09 million -1.01 million N/A N/A N/A
Selling General Administrative 4.76 million 1.01 million N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A
Ebit -1.09 million -1.01 million N/A N/A N/A
Operating Income -886000 -1.01 million N/A N/A N/A
Income Tax Expense 14000 N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A N/A N/A
Net Income From Continuing Operations -1.11 million -1.01 million N/A N/A N/A
Net Income Applicable to Common Shares -1.11 million N/A -1.16 million 249000 N/A
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A N/A 3 million
Change to Liabilities N/A -650000 215000 N/A -257000
Total Cash Flow from Investing Activities N/A -311000 2.45 million N/A 6.5 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities -56000 N/A N/A N/A -19.94 million
Change to Operating Activities N/A -630000 186000 N/A 569000
Change in Cash 79000 N/A N/A N/A -16.64 million
Total Cash from Operating Activities 135000 -1.98 million -1.01 million N/A -3.2 million
Depreciation N/A N/A N/A N/A N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income N/A 464000 -1.66 million N/A -2.81 million
Capital Expenditures N/A N/A N/A N/A N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 770000 2.22 million N/A N/A 2.77 million
Total Stockholder Equity 16.01 million 16.74 million N/A N/A 17.31 million
Other Current Liabilities N/A N/A N/A N/A 1.44 million
Total Assets 16.78 million 18.96 million N/A N/A 20.08 million
Common Stock 1.33 million N/A 1.33 million 1.33 million 1.33 million
Other Current Assets 2.51 million N/A N/A N/A N/A
Retained Earnings -543.64 million -542.53 million -541.52 million -540.36 million -540.61 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets 232000 N/A 315000 1.37 million 1.39 million
Cash 14.04 million 15.81 million N/A N/A 16.58 million
Total Current Liabilities 770000 2.22 million N/A N/A 2.77 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment N/A N/A N/A N/A N/A
Total Current Assets 16.54 million 18.68 million N/A N/A 18.69 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 16.01 million N/A 17.35 million 18.05 million 17.31 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 770000 50000 N/A N/A 271000

Merrimack Pharmaceuticals, Inc (MACK) Chart:

Merrimack Pharmaceuticals, Inc (MACK) News:

Below you will find a list of latest news for Merrimack Pharmaceuticals, Inc (MACK) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Merrimack Pharmaceuticals, Inc (MACK) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-1770CALL0 0214.33TRUE00
2024-05-1780CALL0 0180.29TRUE00
2024-05-1790CALL0 0150.24TRUE00
2024-05-17100CALL0 0110.85TRUE00
2024-05-17110CALL0 0329.36TRUE00
2024-05-17120CALL0 0282.22TRUE00
2024-05-17130CALL0 0116.81TRUE00
2024-05-17140CALL0 00TRUE00
2024-05-17150.15CALL0 700FALSE00
2024-05-17160CALL0 00FALSE00
2024-05-17170CALL0 00FALSE00
2024-05-17180CALL0 00FALSE00
2024-05-17190CALL0 00FALSE00
2024-05-17200CALL0 00FALSE00
2024-05-17210CALL0 00FALSE00
2024-05-17220CALL0 00FALSE00
2024-05-17230CALL0 00FALSE00
2024-05-1770PUT0 00FALSE00
2024-05-1780PUT0 00FALSE00
2024-05-1790PUT0 00FALSE00
2024-05-17100PUT0 00FALSE00
2024-05-17110PUT0 00FALSE00
2024-05-17120PUT0 00FALSE00
2024-05-17130PUT0 00FALSE00
2024-05-17140PUT0 00FALSE00
2024-05-17150.05PUT0 20TRUE00
2024-05-17160PUT0 00TRUE00
2024-05-17170PUT0 078.49TRUE00
2024-05-17180PUT0 0207.49TRUE00
2024-05-17190PUT0 0218.11TRUE00
2024-05-17200PUT0 0226.8TRUE00
2024-05-17210PUT0 0249.27TRUE00
2024-05-17220PUT0 0262.98TRUE00
2024-05-17230PUT0 0275.7TRUE00
2024-06-2130CALL0 0731.98TRUE00
2024-06-2140CALL0 0595.17TRUE00
2024-06-2150CALL0 0430.02TRUE00
2024-06-2160CALL0 0363.96TRUE00
2024-06-2170CALL0 0312.39TRUE00
2024-06-2180CALL0 0269.95TRUE00
2024-06-2190CALL0 0226.42TRUE00
2024-06-21100CALL0 0195.27TRUE00
2024-06-21110CALL0 0167.18TRUE00
2024-06-21122.55CALL0 20168.47TRUE00
2024-06-21132CALL0 1062.67TRUE00
2024-06-21141CALL0 2986.07TRUE00
2024-06-21150.1CALL0 2270FALSE00
2024-06-21160.01CALL0 7460FALSE00
2024-06-21170.49CALL0 120FALSE00
2024-06-21180.25CALL0 700FALSE00
2024-06-21190CALL0 00FALSE00
2024-06-21200.05CALL0 940FALSE00
2024-06-21210CALL0 00FALSE00
2024-06-21250CALL0 00FALSE00
2024-06-2130PUT0 00FALSE00
2024-06-2140.2PUT0 10FALSE00
2024-06-2150PUT0 00FALSE00
2024-06-2160PUT0 00FALSE00
2024-06-2170PUT0 00FALSE00
2024-06-2180PUT0 00FALSE00
2024-06-2190PUT0 00FALSE00
2024-06-21100PUT0 00FALSE00
2024-06-21110PUT0 00FALSE00
2024-06-21120PUT0 00FALSE00
2024-06-21131.65PUT0 330FALSE00
2024-06-21140.1PUT0 170FALSE00
2024-06-21150.43PUT0 100TRUE00
2024-06-21160PUT0 00TRUE00
2024-06-21170PUT0 050.09TRUE00
2024-06-21180PUT0 0127.64TRUE00
2024-06-21190PUT0 0134.28TRUE00
2024-06-21200PUT0 0139.77TRUE00
2024-06-21210PUT0 0153.51TRUE00
2024-06-21250PUT0 0184.11TRUE00
2024-09-2030CALL0 0150.22TRUE00
2024-09-2059.8CALL0 194.53TRUE00
2024-09-2060CALL0 074.48TRUE00
2024-09-2070CALL0 056.29TRUE00
2024-09-2080CALL0 0198.36TRUE00
2024-09-2090CALL0 0172.09TRUE00
2024-09-20104.41CALL0 0120.92TRUE00
2024-09-20110CALL0 0107.03TRUE00
2024-09-20120CALL0 028.16TRUE00
2024-09-20130CALL0 037.91TRUE00
2024-09-20140CALL0 00TRUE00
2024-09-20150.2CALL7 7884.66FALSE0.050.33
2024-09-20160.35CALL0 50FALSE00
2024-09-20170.6CALL0 20FALSE00
2024-09-20180.45CALL0 10FALSE00
2024-09-20190CALL0 00FALSE00
2024-09-20200CALL0 00FALSE00
2024-09-20210CALL0 00FALSE00
2024-09-20250CALL0 00FALSE00
2024-09-2030PUT0 00FALSE00
2024-09-2050PUT0 00FALSE00
2024-09-2060PUT0 00FALSE00
2024-09-2070PUT0 00FALSE00
2024-09-2080PUT0 00FALSE00
2024-09-2090PUT0 00FALSE00
2024-09-20100PUT0 00FALSE00
2024-09-20110PUT0 00FALSE00
2024-09-20120PUT0 00FALSE00
2024-09-20130PUT0 00FALSE00
2024-09-20140.05PUT0 70FALSE00
2024-09-20150.45PUT0 300TRUE00
2024-09-20160PUT0 00TRUE00
2024-09-20170PUT0 034.26TRUE00
2024-09-20185.1PUT0 195.48TRUE00
2024-09-20190PUT0 089.07TRUE00
2024-09-20200PUT0 090TRUE00
2024-09-20210PUT0 098.71TRUE00
2024-09-20250PUT0 0118.55TRUE00
2024-12-2070CALL0 0178.54TRUE00
2024-12-2080CALL0 0153.79TRUE00
2024-12-2090CALL0 0111.56TRUE00
2024-12-20100CALL0 095.79TRUE00
2024-12-20110CALL0 084.63TRUE00
2024-12-20120CALL0 076.87TRUE00
2024-12-20130CALL0 026.27TRUE00
2024-12-20140CALL0 00TRUE00
2024-12-20150CALL0 00FALSE00
2024-12-20160CALL0 00FALSE00
2024-12-20170CALL0 00FALSE00
2024-12-20180CALL0 00FALSE00
2024-12-20190CALL0 00FALSE00
2024-12-20200CALL0 00FALSE00
2024-12-20210CALL0 00FALSE00
2024-12-20220CALL0 00FALSE00
2024-12-20230CALL0 00FALSE00
2024-12-2070PUT0 00FALSE00
2024-12-2080PUT0 00FALSE00
2024-12-2090PUT0 00FALSE00
2024-12-20100PUT0 00FALSE00
2024-12-20110PUT0 00FALSE00
2024-12-20120PUT0 00FALSE00
2024-12-20130PUT0 00FALSE00
2024-12-20140PUT0 00FALSE00
2024-12-20150PUT0 00TRUE00
2024-12-20160PUT0 017.33TRUE00
2024-12-20170PUT0 035.23TRUE00
2024-12-20180PUT0 040.11TRUE00
2024-12-20190PUT0 045.49TRUE00
2024-12-20200PUT0 050.35TRUE00
2024-12-20210PUT0 057.42TRUE00
2024-12-20220PUT0 080.7TRUE00
2024-12-20230PUT0 062.81TRUE00

Merrimack Pharmaceuticals, Inc (MACK) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312520154365/0001193125-20-154365-index.htm
2019-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1274792/000000000019012332/0000000000-19-012332-index.htm
2019-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1274792/000000000019012333/0000000000-19-012333-index.htm
2019-08-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1274792/000000000019012527/0000000000-19-012527-index.htm
2018-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000021545718005865/0000215457-18-005865-index.htm
2019-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924319024347/0000899243-19-024347-index.htm
2019-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924319024349/0000899243-19-024349-index.htm
2019-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924319025789/0000899243-19-025789-index.htm
2019-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924319025791/0000899243-19-025791-index.htm
2019-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924319025794/0000899243-19-025794-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320010463/0000899243-20-010463-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320010465/0000899243-20-010465-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320010517/0000899243-20-010517-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320010518/0000899243-20-010518-index.htm
2020-04-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320011148/0000899243-20-011148-index.htm
2020-04-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320011149/0000899243-20-011149-index.htm
2020-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320020427/0000899243-20-020427-index.htm
2020-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320020428/0000899243-20-020428-index.htm
2020-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320020430/0000899243-20-020430-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320021044/0000899243-20-021044-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320021046/0000899243-20-021046-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320021047/0000899243-20-021047-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320022283/0000899243-20-022283-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320022284/0000899243-20-022284-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320022559/0000899243-20-022559-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000089924320022561/0000899243-20-022561-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000090571819000208/0000905718-19-000208-index.htm
2019-05-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000090571819000433/0000905718-19-000433-index.htm
2020-07-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000090571820000776/0000905718-20-000776-index.htm
2018-11-02SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000092189518002918/0000921895-18-002918-index.htm
2018-12-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000092189518003351/0000921895-18-003351-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519000476/0000921895-19-000476-index.htm
2019-03-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000092189519000739/0000921895-19-000739-index.htm
2019-03-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519000847/0000921895-19-000847-index.htm
2019-03-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519000848/0000921895-19-000848-index.htm
2019-03-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519000849/0000921895-19-000849-index.htm
2019-03-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519000850/0000921895-19-000850-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519001055/0000921895-19-001055-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519001056/0000921895-19-001056-index.htm
2019-04-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000092189519001112/0000921895-19-001112-index.htm
2019-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519001116/0000921895-19-001116-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519001955/0000921895-19-001955-index.htm
2019-07-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002005/0000921895-19-002005-index.htm
2019-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002020/0000921895-19-002020-index.htm
2019-07-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002039/0000921895-19-002039-index.htm
2019-07-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002049/0000921895-19-002049-index.htm
2019-08-06PREC14APreliminary proxy statements, contested solicitationshttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002103/0000921895-19-002103-index.htm
2019-08-13PRRN14ANon-management revised preliminary proxy soliciting materials, contested and otherwisehttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002191/0000921895-19-002191-index.htm
2019-08-19PRRN14ANon-management revised preliminary proxy soliciting materials, contested and otherwisehttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002270/0000921895-19-002270-index.htm
2019-08-22DFAN14AAdditional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002303/0000921895-19-002303-index.htm
2019-09-24DFAN14AAdditional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002451/0000921895-19-002451-index.htm
2019-09-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002452/0000921895-19-002452-index.htm
2019-11-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000092189519002823/0000921895-19-002823-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000092189520000542/0000921895-20-000542-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000110465920021226/0001104659-20-021226-index.htm
2018-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312518211983/0001193125-18-211983-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312518240346/0001193125-18-240346-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312518320126/0001193125-18-320126-index.htm
2019-02-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519042418/0001193125-19-042418-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519064654/0001193125-19-064654-index.htm
2019-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1274792/000119312519064697/0001193125-19-064697-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519107839/0001193125-19-107839-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519127241/0001193125-19-127241-index.htm
2019-04-3010-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1274792/000119312519129368/0001193125-19-129368-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519143634/0001193125-19-143634-index.htm
2019-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519161299/0001193125-19-161299-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519180123/0001193125-19-180123-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519186553/0001193125-19-186553-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519187371/0001193125-19-187371-index.htm
2019-07-018-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519187374/0001193125-19-187374-index.htm
2019-07-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519193279/0001193125-19-193279-index.htm
2019-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519195208/0001193125-19-195208-index.htm
2019-07-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519204007/0001193125-19-204007-index.htm
2019-08-05PREC14APreliminary proxy statements, contested solicitationshttps://www.sec.gov/Archives/edgar/data/1274792/000119312519213083/0001193125-19-213083-index.htm
2019-08-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1274792/000119312519223186/0001193125-19-223186-index.htm
2019-08-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1274792/000119312519223587/0001193125-19-223587-index.htm
2019-08-16PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1274792/000119312519223588/0001193125-19-223588-index.htm
2019-08-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1274792/000119312519229227/0001193125-19-229227-index.htm
2019-09-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1274792/000119312519238418/0001193125-19-238418-index.htm
2019-09-19DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1274792/000119312519249100/0001193125-19-249100-index.htm
2019-09-19SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000119312519249231/0001193125-19-249231-index.htm
2019-09-19SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000119312519249241/0001193125-19-249241-index.htm
2019-09-20PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/1274792/000119312519250054/0001193125-19-250054-index.htm
2019-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519250720/0001193125-19-250720-index.htm
2019-09-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1274792/000119312519250722/0001193125-19-250722-index.htm
2019-09-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1274792/000119312519256009/0001193125-19-256009-index.htm
2019-09-26CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1274792/000119312519256019/0001193125-19-256019-index.htm
2019-09-30SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000119312519257723/0001193125-19-257723-index.htm
2019-09-30SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000119312519257726/0001193125-19-257726-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519270407/0001193125-19-270407-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312519304912/0001193125-19-304912-index.htm
2019-12-038-A12GRegistration of securities [Section 12(g)]https://www.sec.gov/Archives/edgar/data/1274792/000119312519304913/0001193125-19-304913-index.htm
2020-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312520044782/0001193125-20-044782-index.htm
2020-03-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1274792/000119312520072857/0001193125-20-072857-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312520090100/0001193125-20-090100-index.htm
2020-04-10PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1274792/000119312520103890/0001193125-20-103890-index.htm
2020-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1274792/000119312520115075/0001193125-20-115075-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312520154365/0001193125-20-154365-index.htm
2020-07-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1274792/000119312520197975/0001193125-20-197975-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312520212544/0001193125-20-212544-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1274792/000119312520286284/0001193125-20-286284-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118038075/0001209191-18-038075-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118038077/0001209191-18-038077-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118038080/0001209191-18-038080-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118038082/0001209191-18-038082-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118062433/0001209191-18-062433-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118062435/0001209191-18-062435-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118062437/0001209191-18-062437-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118062438/0001209191-18-062438-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919118062440/0001209191-18-062440-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1274792/000120919119028674/0001209191-19-028674-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000121465919000909/0001214659-19-000909-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1274792/000125889720001153/0001258897-20-001153-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459018019659/0001564590-18-019659-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459018027759/0001564590-18-027759-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1274792/000156459019006385/0001564590-19-006385-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459019018299/0001564590-19-018299-index.htm
2019-07-1710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459019025092/0001564590-19-025092-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459019042925/0001564590-19-042925-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1274792/000156459020010531/0001564590-20-010531-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459020022829/0001564590-20-022829-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459020038076/0001564590-20-038076-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1274792/000156459020050520/0001564590-20-050520-index.htm

Merrimack Pharmaceuticals, Inc (MACK) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Merrimack Pharmaceuticals, Inc (MACK). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 324%
Institutional Ownership: 6031%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-07-22GARY L CROCKEROfficerSell5,986.003.0418,208.810.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020430/0000899243-20-020430-index.htm
2020-07-22GARY L CROCKEROfficerSell17,000.003.2054,434.000.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020430/0000899243-20-020430-index.htm
2019-07-11Jason Aryeh10% Share HolderBuy100.005.71571.00100.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519002005/0000921895-19-002005-index.htm
2019-04-0522NW, LP10% Share HolderBuy50,000.006.12305,760.001,142,263.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001056/0000921895-19-001056-index.htm
2019-04-0822NW, LP10% Share HolderBuy32,873.005.81191,034.861,175,136.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001056/0000921895-19-001056-index.htm
2019-04-1522NW, LP10% Share HolderBuy30,110.005.73172,530.301,205,246.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001116/0000921895-19-001116-index.htm
2019-04-1622NW, LP10% Share HolderBuy20,450.005.95121,636.601,225,696.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001116/0000921895-19-001116-index.htm
2019-04-1722NW, LP10% Share HolderBuy16,200.006.0097,156.261,241,896.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001116/0000921895-19-001116-index.htm
2020-07-22Eric AndersenDirectorBuy17,404.003.2055,727.61193,990.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020428/0000899243-20-020428-index.htm
2020-07-22Eric AndersenDirectorBuy33,192.003.04100,966.74227,182.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020428/0000899243-20-020428-index.htm
2020-08-11Eric AndersenDirectorBuy14,030.003.4548,437.17241,212.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022284/0000899243-20-022284-index.htm
2020-08-12Eric AndersenDirectorBuy2,000.003.496,986.00243,212.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022284/0000899243-20-022284-index.htm
2019-07-12Jason Aryeh10% Share HolderBuy2,400.005.7113,704.002,500.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519002005/0000921895-19-002005-index.htm
2019-07-12Jason Aryeh10% Share HolderBuy1,000.005.625,620.003,500.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519002005/0000921895-19-002005-index.htm
2019-07-16Jason Aryeh10% Share HolderBuy302.005.441,642.883,802.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519002020/0000921895-19-002020-index.htm
2019-04-08JFL Capital Management, LLC10% Share HolderBuy4,506.005.7325,803.16489,532.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001055/0000921895-19-001055-index.htm
2019-06-28JFL Capital Management, LLC10% Share HolderBuy9,662.005.9557,440.59499,194.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001955/0000921895-19-001955-index.htm
2020-04-03Noah G. LevyDirectorBuy4,461.002.5911,568.27500,081.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010465/0000899243-20-010465-index.htm
2020-04-06Noah G. LevyDirectorBuy2,507.003.007,512.23502,588.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010465/0000899243-20-010465-index.htm
2019-07-01JFL Capital Management, LLC10% Share HolderBuy3,934.006.0023,615.41503,128.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001955/0000921895-19-001955-index.htm
2020-04-07Noah G. LevyDirectorBuy2,448.003.037,421.85505,036.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010517/0000899243-20-010517-index.htm
2020-04-20Noah G. LevyDirectorBuy965.003.253,136.25506,001.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320011149/0000899243-20-011149-index.htm
2020-04-21Noah G. LevyDirectorBuy591.003.251,920.75506,592.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320011149/0000899243-20-011149-index.htm
2019-07-02JFL Capital Management, LLC10% Share HolderBuy7,024.005.8541,076.35510,152.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001955/0000921895-19-001955-index.htm
2020-07-22Noah G. LevyDirectorBuy33,435.003.20107,058.87540,027.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020427/0000899243-20-020427-index.htm
2020-07-22Noah G. LevyDirectorBuy40,488.003.04123,160.45580,515.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020427/0000899243-20-020427-index.htm
2020-08-11Noah G. LevyDirectorBuy5,856.003.4520,217.84586,371.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022283/0000899243-20-022283-index.htm
2020-08-12Noah G. LevyDirectorBuy834.003.492,913.16587,205.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022283/0000899243-20-022283-index.htm
2020-08-13Noah G. LevyDirectorBuy254.003.50889.00587,459.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022561/0000899243-20-022561-index.htm
2020-04-03Eric AndersenDirectorBuy10,750.002.6027,924.20677,077.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010463/0000899243-20-010463-index.htm
2020-04-06Eric AndersenDirectorBuy6,043.003.0018,107.85683,120.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010463/0000899243-20-010463-index.htm
2020-04-03Noah G. LevyDirectorBuy6,289.002.5916,308.63683,835.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010465/0000899243-20-010465-index.htm
2020-04-06Noah G. LevyDirectorBuy3,535.003.0010,592.63687,370.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010465/0000899243-20-010465-index.htm
2020-04-07Eric AndersenDirectorBuy5,899.003.0317,884.59689,019.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010518/0000899243-20-010518-index.htm
2020-04-07Noah G. LevyDirectorBuy3,451.003.0310,462.74690,821.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320010517/0000899243-20-010517-index.htm
2020-04-20Eric AndersenDirectorBuy2,325.003.257,556.25691,344.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320011148/0000899243-20-011148-index.htm
2020-04-20Noah G. LevyDirectorBuy1,360.003.254,420.00692,181.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320011149/0000899243-20-011149-index.htm
2020-04-21Eric AndersenDirectorBuy1,424.003.254,628.00692,768.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320011148/0000899243-20-011148-index.htm
2020-04-21Noah G. LevyDirectorBuy833.003.252,707.25693,014.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320011149/0000899243-20-011149-index.htm
2019-04-05JFL Capital Management, LLC10% Share HolderBuy26,288.005.95156,466.18703,524.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001055/0000921895-19-001055-index.htm
2019-04-08JFL Capital Management, LLC10% Share HolderBuy6,484.005.7337,129.98710,008.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001055/0000921895-19-001055-index.htm
2019-06-28JFL Capital Management, LLC10% Share HolderBuy13,902.005.9582,647.39723,910.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001955/0000921895-19-001955-index.htm
2019-07-01JFL Capital Management, LLC10% Share HolderBuy5,659.006.0033,970.41729,569.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001955/0000921895-19-001955-index.htm
2019-07-02JFL Capital Management, LLC10% Share HolderBuy10,107.005.8559,105.74739,676.00https://www.sec.gov/Archives/edgar/data/1274792/000092189519001955/0000921895-19-001955-index.htm
2020-07-22Noah G. LevyDirectorBuy46,745.003.20149,677.49739,759.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020427/0000899243-20-020427-index.htm
2020-07-22Eric AndersenDirectorBuy62,775.003.20201,005.55755,543.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020428/0000899243-20-020428-index.htm
2020-07-22Noah G. LevyDirectorBuy56,606.003.04172,189.79796,365.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020427/0000899243-20-020427-index.htm
2020-08-11Noah G. LevyDirectorBuy8,186.003.4528,262.17804,551.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022283/0000899243-20-022283-index.htm
2020-08-12Noah G. LevyDirectorBuy1,166.003.494,072.84805,717.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022283/0000899243-20-022283-index.htm
2020-08-13Noah G. LevyDirectorBuy354.003.501,239.00806,071.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022561/0000899243-20-022561-index.htm
2020-07-22Eric AndersenDirectorBuy63,903.003.04194,386.54819,446.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320020428/0000899243-20-020428-index.htm
2020-08-13Eric AndersenDirectorBuy609.003.502,131.50820,055.00https://www.sec.gov/Archives/edgar/data/1274792/000089924320022559/0000899243-20-022559-index.htm